Literature DB >> 20226512

Sublingual desensitization for buprenorphine hypersensitivity.

Lisa M Stutius, Itai Pessach, Joanne Lee, Mindy S Lo, Sharon Levy, Patricia Schram, Miriam Schizer, Jackson Wong, Wanda Phipatanakul, Dale T Umetsu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20226512      PMCID: PMC2850949          DOI: 10.1016/j.jaci.2009.12.982

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  8 in total

1.  Pruritus with sublingual buprenorphine.

Authors:  M Woodham
Journal:  Anaesthesia       Date:  1988-09       Impact factor: 6.955

2.  Opiate-sensitivity: clinical characteristics and the role of skin prick testing.

Authors:  S M Nasser; P W Ewan
Journal:  Clin Exp Allergy       Date:  2001-07       Impact factor: 5.018

Review 3.  Buprenorphine for the treatment of opioid dependence.

Authors:  Lisa A Boothby; Paul L Doering
Journal:  Am J Health Syst Pharm       Date:  2007-02-01       Impact factor: 2.637

4.  Anaphylaxis following administration of papaveretum. Case report: Implication of IgE antibodies that react with morphine and codeine, and identification of an allergenic determinant.

Authors:  D G Harle; B A Baldo; N J Coroneos; M M Fisher
Journal:  Anesthesiology       Date:  1989-10       Impact factor: 7.892

5.  Allergic contact dermatitis from transdermal buprenorphine.

Authors:  Kim Vander Hulst; Elisabeth Parera Amer; Claude Jacobs; Virginie Dewulf; Marie Baeck; Ramón M Pujol Vallverdú; Ana Giménez-Arnau; Dominique Tennstedt; An Goossens
Journal:  Contact Dermatitis       Date:  2008-12       Impact factor: 6.600

Review 6.  Mechanisms of sublingual immunotherapy.

Authors:  Guy Scadding; Stephen Durham
Journal:  J Asthma       Date:  2009-05       Impact factor: 2.515

Review 7.  Drug-induced urticarias.

Authors:  Pascale Mathelier-Fusade
Journal:  Clin Rev Allergy Immunol       Date:  2006-02       Impact factor: 8.667

8.  Hypersensitivity reactions to drugs: evaluation and management.

Authors:  Gillian M Shepherd
Journal:  Mt Sinai J Med       Date:  2003-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.